Acquired weakness in the ICU: Critical illness myopathy and polyneuropathy

Minerva Anestesiologica

Volumn 72, Issue 6, 2006, Pages 401-406

  Khan, J ^a,b   Burnham, E L ^a   Moss, M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

Critical illness; Myopathy; Neuromuscular disease; Polyneuropathy; Sepsis

Indexed keywords

AMINOGLYCOSIDE; ARGININE; BRANCHED CHAIN AMINO ACID; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GROWTH HORMONE; NEUROMUSCULAR BLOCKING AGENT; OXANDROLONE; STEROID;

ANAMNESIS; ARTICLE; CLINICAL FEATURE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ELECTROMYOGRAM; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LABORATORY TEST; MUSCLE WEAKNESS; MYOPATHY; NERVE CONDUCTION; NUTRITIONAL SUPPORT; PARESIS; PATHOGENESIS; POLYNEUROPATHY; PROGNOSIS; QUALITY OF LIFE; SEPSIS; TREATMENT OUTCOME;

CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; MUSCULAR DISEASES; POLYNEUROPATHIES;

EID: 33745245069     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-31.
2. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1986;49:563-73.
3. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998;21:610-7.
4. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-93.
5. Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. Jama 1999;281:354-60.
6. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;2:615.
7. Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992;42:2082-7.
8. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 2000;28:34-45.
9. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-9.
10. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005;32:140-63.
11. Gutmann L, Gutmann L. Critical illness neuropathy and myopathy. Arch Neurol 1999;56:527-8.
12. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P et al. Critical illness myopathy and neuropathy. Lancet 1996;347:1579-82.
13. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993;19:323-8.
14. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-84.
15. Leijten FS, de Weerd AW. Critical illness polyneuropathy, facts and controversies. J Peripher Nerv Syst 1996;1:28-33.
16. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996;24:1408-6.
17. Bolton CF. AAEM minimonograph #40: clinical neurophysiology of the respiratory system. Muscle Nerve 1993;16:809-18.
18. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997;20:665-73.
19. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731-6.
20. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-22.
21. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40:645-54.
22. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110 (Pt 4):819-41.
23. Schwarz J, Planck J, Briegel J, Straube A. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 1997;20:696-701.
24. Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003;31: 1012-6.
25. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002;30:2022-9.
26. Griffiths RD, Allen KD, Andrews FJ, and Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 2002; 18:546-52.
27. Berard M, Zazzo J, Condat P. Total parenteral nutrition enriched with arginine and glutamate generates and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit Care Med 2000;28:3637.
28. Hammarqvist F, Luo J-L, Cotgreave IA, Andersson K, Wernerman J. Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med 1997; 25:78-4.
29. Ortolani O, Conti A, De Gaudio AR. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000;161:1907.
30. Chang DW, DeSanti L, Demling RH. Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 1998; 10:155-60.
31. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinck XG et al. Increased mortality assocaited with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-92.
32. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
33. Van den Berghe G, Wilmers A, Hermans G, Meerssemen W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.